Home > Healthcare > Medical Devices > Therapeutic Devices > Intravenous Infusion Pump Market
Intravenous Infusion Pump Market size exceeded USD 5.5 billion in 2022 and is expected to depict over 5% CAGR through 2023-2032, as a result of the growing prevalence of cancer and other chronic diseases.
Intravenous (IV) therapy is gaining ground to provide greater relief to chronic disease patients when physician-prescribed oral or topical routes fall short. This therapy can bypass obstacles in oral medication administration, as it can be delivered directly into the bloodstream. Non-communicable or chronic diseases including cancer are on the rise globally, mainly due to the adoption of sedentary lifestyles, increased tobacco, alcohol, and cigarette consumption, and other unhealthy habits.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Intravenous Infusion Pump Market Size in 2022: | USD 5.7 Billion |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 5.4% |
2032 Value Projection: | USD 9.7 Billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 200 |
Tables, Charts & Figures: | 357 |
Segments covered: | Technology, Component, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
Likewise, with the availability of skilled healthcare professionals and medical equipment, healthcare expenditure continues to surge, creating growth opportunities for intravenous fluids infusion pump developers. IV infusion pumps are equipped with warning alerts, alarms, and other safety features intended to be activated when issues arise. However, the complexity and multiple steps associated with IV administration may lead to errors and assert a negative influence on intravenous equipment production.